Knie Robb 4
4 · Hoth Therapeutics, Inc. · Filed Jan 15, 2025
Insider Transaction Report
Form 4
Knie Robb
DirectorCEO and President
Transactions
- Award
Options
2025-01-14+93,000→ 93,000 totalExercise: $1.55From: 2025-01-14Exp: 2035-01-14→ Common Stock (93,000 underlying) - Award
Options
2025-01-14+7,000→ 7,000 totalExercise: $1.55From: 2025-01-14Exp: 2035-01-14→ Common Stock (7,000 underlying)
Footnotes (2)
- [F1]The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan, as amended, and vested in full upon grant.
- [F2]The options were issued pursuant to the Issuer's Amended and Restated 2022 Equity Incentive Plan, as amended, and vested in full upon grant.